Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus

Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus

Type 2 diabetes mellitus (T2DM) is prevalent, with a dramatic increase in recent years. Moreover, its microvascular and macrovascular complications cause significant societal issues. The demand for new and effective antidiabetic therapies grows with each passing day and motivates organizations and i...

Full description

Bibliographic Details
Main Authors: Wei Zhu, Wen Huang, Zhiqiang Xu, Mengda Cao, Qiaoli Hu, Chen Pan, Miao Guo, Ji-Fu Wei, Hongyu Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Pharmacology
Subjects:
type 2 diabetes mellitus
antihyperglycemic
patent
review
therapy
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00586/full

Similar Items

Similar Items